Business
Psychedelic biotech Psylo raises first funds – The Australian Financial Review
Startmate company Psylo is the latest company to attract funding for its pre-clinical psychedelic research.
The space is also attracting big investment dollars in the US, UK and Europe, with Beckley Psytech raising $US80 million in August, Atai Life Sciences raising $225 million for a NASDAQ listing in 2020 and new Chicago-based venture capital group Palo Santo…
Continue Reading
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General12 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals